Conclusions. This study showed that BAK-preserved travoprost 0.004% is an effective medication in newly diagnosed POAG patients, but its long-term use may negatively influence ocular surface health by disrupting the tear film stability. Further studies are needed to better understand the clinical effects of different preservative types and concentrations on the ocular surface.
PMID: 23971041 [PubMed – in process] (Source: Biomed Res)
MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.